PROVIDING INCENTIVES TO INDUSTRY TO DEVELOP NEW CONTRACEPTIVES

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Albert, Randi M.	en_US
dc.date.accessioned	2012-07-06T21:35:11Z
dc.date.issued	1995	en_US
dc.identifier.citation	PROVIDING INCENTIVES TO INDUSTRY TO DEVELOP NEW CONTRACEPTIVES (1995 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8965583
dc.description.abstract	This paper will discuss why this lack of contraceptive alternatives poses such a tremendous problem, and will describe the birth control options currently available. Additionally, the paper will describe the four main reasons for the lack of progress in contraceptive development: a deluge of product liability suits; negative political pressures; the large expense of testing products intended for a healthy population; and insufficient research and funding. Finally, the paper will offer some proposals for addressing each of these problems.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	NRCCD	en
dc.subject	contraceptive alternatives	en
dc.title	PROVIDING INCENTIVES TO INDUSTRY TO DEVELOP NEW CONTRACEPTIVES	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-07-06T21:35:11Z